Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Nielsen

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Diabetologia|May 26, 2005
Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker ratsB R Gedulin, P Smith, K S Prickett, et al.
Cancer Research|December 22, 1999
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer modelsL L Nielsen, B Shi, G Hajian, et al.
Diabetes, Obesity & Metabolism|June 17, 2006
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitusR E Ratner, D Maggs, L L Nielsen, et al.
The American Journal of Pathology|December 14, 1999
The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsiesM J Grace, L Xie, M L Musco, et al.
Cancer Gene Therapy|December 29, 2000
Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft modelsS F Wen, L Xie, M McDonald, et al.
International Journal of Cancer|November 3, 1995
Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 statusM Andersson, H Wallin, M Jönsson, et al.
European Journal of Immunology|October 10, 2001
Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bondsL Ostergaard Pedersen, M H Nissen, N J Hansen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001
Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatmentI A Atencio, J B Avanzini, D Johnson, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Diabetologia|May 26, 2005
Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker ratsB R Gedulin, P Smith, K S Prickett, et al.
Cancer Research|December 22, 1999
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer modelsL L Nielsen, B Shi, G Hajian, et al.
Diabetes, Obesity & Metabolism|June 17, 2006
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitusR E Ratner, D Maggs, L L Nielsen, et al.
The American Journal of Pathology|December 14, 1999
The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsiesM J Grace, L Xie, M L Musco, et al.
Cancer Gene Therapy|December 29, 2000
Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft modelsS F Wen, L Xie, M McDonald, et al.
International Journal of Cancer|November 3, 1995
Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 statusM Andersson, H Wallin, M Jönsson, et al.
European Journal of Immunology|October 10, 2001
Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bondsL Ostergaard Pedersen, M H Nissen, N J Hansen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001
Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatmentI A Atencio, J B Avanzini, D Johnson, et al.
Pageof 4